(Q41188327)

28 September 2017

title

Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells (English)

1 reference

28 September 2017

0 references

Spiller OB

1

1 reference

28 September 2017

Morgan BP

series ordinal

2

1 reference

28 September 2017

Tufaro F

series ordinal

3

1 reference

28 September 2017

Devine DV

series ordinal

4

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

European Journal of Immunology

28 September 2017

published in

1 reference

28 September 2017

volume

26

1 reference

28 September 2017

issue

7

1 reference

28 September 2017

page(s)

1532-1538

1 reference

Virus-Specific IgG and IgM Antibodies in Normal and Immunocompromised Subjects Infected with Cytomegalovirus

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

The development of immunofluorescent antibodies as compared with complement-fixing and virus-neutralizing antibodies in human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

Functional properties of membrane cofactor protein of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

Neutralization and sensitization of cytomegalovirus by IgG antibody, anti-IgG antibody, and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Cytolytic IgM Antibody to Cytomegalovirus in Primary Cytomegalovirus Infection in Humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Epstein-Barr virus regulates activation and processing of the third component of complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Regulatory system of guinea-pig complement C3b: Tests for compatibility of guinea-pig factors H and I with human factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Localization of the human CD59 gene by fluorescence in situ hybridization and pulsed-field gel electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Stimulation of Cellular Thymidine Kinases by Human Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Induction of cellular hsp70 expression by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Activation of Proto-Oncogenes: an Immediate Early Event in Human Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Enhanced survival of ultraviolet-irradiated herpes simplex virus in human cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Increased expression of complement decay-accelerating factor during activation of human neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Generation of human cytomegalovirus-specific cytotoxic T-lymphocytes in a short-term culture

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260719

7 January 2021

Identifiers

DOI

10.1002/EJI.1830260719

1 reference

28 September 2017

1 reference